SCHEMBL4694058

SCHEMBL4694058

CN1Cc2ccccc2CC1C(=O)N1CC2CN(CC[C@H](N)c3ccccc3)CC2C1

nearest known ligand 0.41

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 11/20 0.41
CCL5 P13501 6/20 0.39
PDE2A O00408 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
NR4A1 P22736 1/20 0.37
ESR2 Q92731 1/20 0.37
PREP P48147 2/20 0.37
ACE P12821 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopentane SCHEMBL4690335 0.84 CCR5 (0.53) CCR5
SCHEMBL4693061 0.79 CCR5 (0.51) CCR5CCL5ALDH1A1
SCHEMBL4692783 0.78 CCR5 (0.60) CCR5CCL5
SCHEMBL4695013 0.78 CCR5 (0.52) CCR5CCL5ALDH1A1
SCHEMBL4692082 0.77 CCR5 (0.54) CCR5CCL5
SCHEMBL4693210 0.77 CCR5 (0.56) CCR5CCL5
SCHEMBL4692279 0.77 CCR5 (0.44) CCR5CCL5
SCHEMBL4695378 0.76 CCL5 (0.52) CCR5CCL5
SCHEMBL4692063 0.76 CCL5 (0.51) CCR5CCL5
SCHEMBL4691540 0.76 CCR5 (0.56) CCR5CCL5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP claimed
EP-1761542-A2 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS F.HOFFMANN-LA ROCHE AG (CH) 2007-03-14 EP claimed
WO-2005121145-A2 OCTAHYDRO-PYRROLO[3,4-C] DERIVATIVES AND THEIR USE AS ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 WO claimed
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP disclosed